Publications


2016

Differences in mammographic density between Asian and Caucasian populations: a comparative analysis.

Rajaram N, Mariapun S, Eriksson M, Tapia J, Kwan PY, Ho WK, Harun F, Rahmat K, Czene K, et al.


Breast Cancer Res Treat
201611
https://pubmed.ncbi.nlm.nih.gov/27864652/

rs2735383, located at a microRNA binding site in the 3’UTR of NBS1, is not associated with breast cancer risk.

Liu J, Lončar I, Collée JM, Bolla MK, Dennis J, Michailidou K, Wang Q, Andrulis IL, et al.


Sci Rep
201611
https://pubmed.ncbi.nlm.nih.gov/27845421/

Chemotherapy, Genetic Susceptibility, and Risk of Venous Thromboembolism in Breast Cancer Patients. 

Brand JS, Hedayati E, Humphreys K, Ludvigsson JF, Johansson AL, Bergh J, Hall P, Czene K.


Clin Cancer Res
201611
https://pubmed.ncbi.nlm.nih.gov/27803117/

Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21. 

Hamdi Y, Soucy P, Adoue V, Michailidou K, Canisius S, Lemaçon A, Droit A, Andrulis IL, et al.


Oncotarget
201610
https://pubmed.ncbi.nlm.nih.gov/27792995/

Common diseases as determinants of menopausal age.

Li J, Eriksson M, Czene K, Hall P, Rodriguez-Wallberg KA.


Hum Reprod
201610
https://pubmed.ncbi.nlm.nih.gov/27798047/

Time-dependent risk and predictors of venous thromboembolism in breast cancer patients: A population-based cohort study.

Brand JS, Hedayati E, Bhoo-Pathy N, Bergh J, Hall P, Humphreys K, Ludvigsson JF, Czene K.


Cancer
201610
https://pubmed.ncbi.nlm.nih.gov/27727456/

Genetic modifiers of CHEK2*1100delC-associated breast cancer risk.

Muranen TA, Greco D, Blomqvist C, Aittomäki K, Khan S, Hogervorst F, Verhoef S, Pharoah PD, et al.


Genet Med
201610
https://pubmed.ncbi.nlm.nih.gov/27711073/

Novel mammographic image features differentiate between interval and screen-detected breast cancer: a case-case study. 

Strand F, Humphreys K, Cheddad A, Törnberg S, Azavedo E, Shepherd J, Hall P, Czene K.


Breast Cancer Res
201610
https://pubmed.ncbi.nlm.nih.gov/27716311/

Risk of hospitalisation and death due to bone fractures after breast cancer: a registry-based cohort study.

Colzani E, Clements M, Johansson AL, Liljegren A, He W, Brand J, Adolfsson J, Fornander T, Hall P, Czene K.


Br J Cancer
201610
https://pubmed.ncbi.nlm.nih.gov/27701383/

Patient survival and tumor characteristics associated with CHEK2:p.I157T – findings from the Breast Cancer Association Consortium. 

Muranen TA, Blomqvist C, Dörk T, Jakubowska A, Heikkilä P, Fagerholm R, Greco D, Aittomäki K, et al.


Breast Cancer Res
201610
https://pubmed.ncbi.nlm.nih.gov/27716369/

Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation.

Ghoussaini M, French JD, Michailidou K, Nord S, Beesley J, Canisus S, Hillman KM, Kaufmann S, Sivakumaran H, et al.


Am J Hum Genet
201609
https://pubmed.ncbi.nlm.nih.gov/27640304/

Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer.

Shi J, Zhang Y, Zheng W, Michailidou K, Ghoussaini M, Bolla MK, Wang Q, Dennis J, et al.


Int J Cancer
201609
https://pubmed.ncbi.nlm.nih.gov/27087578/

Longitudinal fluctuation in mammographic percent density differentiates between interval and screen-detected breast cancer. 

Strand F, Humphreys K, Eriksson M, Li J, Andersson TM, Törnberg S, Azavedo E, Shepherd J, et al.


Int J Cancer
201609
https://pubmed.ncbi.nlm.nih.gov/27615710/

Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs).

Darabi H, Beesley J, Droit A, Kar S, Nord S, Moradi Marjaneh M, Soucy P, Michailidou K, et al.


Sci Rep
201609
https://pubmed.ncbi.nlm.nih.gov/27600471/

Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus. 

Lawrenson K, Kar S, McCue K, Kuchenbaeker K, Michailidou K, Tyrer J, Beesley J, Ramus SJ, et al.


Nat Commun
201609
https://pubmed.ncbi.nlm.nih.gov/27601076/

Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Decadence.

Guo Y, Warren Andersen S, Shu XO, Michailidou K, Bolla MK, Wang Q, Garcia-Closas M, Milne RL, et al.


PLoS Med
201608
https://pubmed.ncbi.nlm.nih.gov/27551723/

Worse quality of life in young and recently-diagnosed breast cancer survivors compared to female survivors of other cancers: A cross-sectional study. 

Li J, Humphreys K, Eriksson M, Dar H, Brandberg Y, Hall P, Czene K.


Int J Cancer
201608
https://pubmed.ncbi.nlm.nih.gov/27486698/

An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression.

Wyszynski A, Hong CC, Lam K, Michailidou K, Lytle C, Yao S, Zhang Y, Bolla MK, Wang Q, Dennis J, Hopper JL, Southey MC, Schmidt MK, et al.


Hum Mol Genet
201607
https://pubmed.ncbi.nlm.nih.gov/27402876/

Amount of stroma is associated with mammographic density and stromal expression of oestrogen receptor in normal breast tissues. 

Gabrielson M, Chiesa F, Paulsson J, Strell C, Behmer C, Rönnow K, Czene K, Östman A,  Hall P.


Breast Cancer Res Treat
201606
https://pubmed.ncbi.nlm.nih.gov/27349429/

Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus.

Hisani N. Horne, Charles C. Chung, Han Zhang, Kai Yu, Ludmila Prokunina-Olsson, Kyriaki Michailidou, Manjeet K. Bolla, et al.


PLoS One
201606
https://pubmed.ncbi.nlm.nih.gov/27556229/